Seliforant
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Apr 12, 2017 (NCT03110458)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Histamine H4 receptorINHIBITOR
HRH4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sens-111
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03110458 | Phase 2/Phase 3 (Phase 3) | Apr 12, 2017 | Ludwig Maximilians University, Sensorion |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ludwig Maximilians University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Sensorion | For profit | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1